USP General Chapter <800> governs how hazardous drugs (HDs) are received, stored, compounded, and handled so that workers, patients, and the environment are protected from exposure. For the building, its defining demand is a dedicated negative-pressure containment room — a space whose entire reason for existing is to keep hazardous-drug particulate and vapor inside the room, the inverse of the positive-pressure logic that protects a sterile product. Getting the containment envelope, exhaust path, and pressure cascade right is the hardest single thing about the modern pharmacy build, and it is unforgiving: a room that leaks contamination outward fails its purpose no matter how clean its air looks on a particle count.
This article covers the hazardous-drug containment scope specifically — the negative-pressure rooms, primary engineering controls for HDs, exhaust, and the containment design that distinguishes <800> from sterile compounding. The positive-pressure sterile suite is covered by the sibling Article on the USP <797> cleanroom; shared anteroom and gowning flow, the controlled-substance vault, the cleanroom HVAC/ISO mechanics, and certification/environmental sampling are each covered by their own sibling Articles.
USP <800>, "Hazardous Drugs — Handling in Healthcare Settings," applies to all healthcare personnel and all entities that handle HD preparations — not just compounding pharmacies, but nursing, receiving, transport, and waste handling. It became official on December 1, 2019, and is widely enforced. Although USP itself does not inspect or accredit, <800> is made enforceable in practice through several channels: many state boards of pharmacy adopt it by reference, accreditation organizations (The Joint Commission, DNV, HFAP) survey to it, and OSHA can cite exposure hazards under the General Duty Clause, often referencing the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings as the authoritative definition of what counts as an HD.
The conceptual break from sterile compounding is the direction of protection:
When a drug is both sterile and hazardous (the common case for chemotherapy IVs), both objectives must be met simultaneously — a sterile environment inside a negative-pressure containment room — which is why this is the most technically demanding space in the suite.
The heart of <800> compliance is the HD compounding area held at negative pressure relative to adjacent spaces, so that the natural leakage of air is always into the room. The chapter establishes a required pressure differential for the containment room.
| Parameter | Typical / required value | Notes |
|---|---|---|
| Pressure differential | Negative 2.5 to 5 Pa (≈ 0.01–0.02 in. w.c.) to adjacent spaces | A bounded range, not just "negative" — too little is unreliable; excessive negativity strains door operation and balance |
| Air changes per hour (ACH) | At least 30 ACH total for the room | Combines HEPA-filtered supply and exhaust; aligns with ISO Class 7 cleanroom expectations for sterile HD work |
| Exhaust | Externally vented, 100% exhaust to outdoors | Recirculation back into the building is not acceptable for the containment room |
| Air classification (sterile HD) | ISO Class 7 for the negative-pressure buffer room | Non-sterile HD compounding may be done in an unclassified C-PEC under containment, but still negative and externally vented |
| Containment of containment | Negative room contained within a negative or neutral anteroom, with the overall cascade carefully sequenced | The anteroom/gowning sequence is detailed in the sibling gowning-flow Article |
A practical design tension lives in that pressure band. The room must be reliably negative under all operating conditions — doors closed, doors briefly opened, pass-through cycling, C-PEC running — yet not so aggressively negative that doors are hard to open or the cascade becomes unstable. Achieving a stable negative differential within the band, verified continuously, is a controls and air-balance problem as much as an architectural one. The detailed HVAC and pressure-cascade engineering is covered in the sibling Article on cleanroom HVAC and ISO classification; what matters here is that the containment intent drives every one of those decisions.
USP <800> uses a layered "containment" vocabulary. The room itself is the secondary engineering control (C-SEC); the device the technician actually compounds in is the primary engineering control (C-PEC). For HDs, the C-PEC must provide both worker protection and (for sterile work) product protection, and it must be externally vented.
Common C-PECs for hazardous-drug work:
A core mechanical implication: HD primary controls are vented to the outside, and many configurations require the exhaust blower to run continuously and be on emergency/standby power so containment is never lost. The interaction between the C-PEC's exhaust requirement and the room's exhaust-driven negative pressure must be coordinated early between pharmacy planning, the equipment vendor, and the mechanical engineer.